$88.49
0.01% today
NYSE, Apr 02, 09:15 pm CET
ISIN
IE00BTN1Y115
Symbol
MDT

Medtronic Stock price

$88.49
-5.81 6.16% 1M
-1.51 1.68% 6M
+8.61 10.78% YTD
+1.47 1.69% 1Y
-24.03 21.36% 3Y
+4.38 5.21% 5Y
+12.35 16.22% 10Y
NYSE, Closing price Tue, Apr 01 2025
-1.37 1.52%
ISIN
IE00BTN1Y115
Symbol
MDT
Sector

Key metrics

Market capitalization $113.49b
Enterprise Value $132.40b
P/E (TTM) P/E ratio 26.90
EV/FCF (TTM) EV/FCF 24.22
EV/Sales (TTM) EV/Sales 3.99
P/S ratio (TTM) P/S ratio 3.42
P/B ratio (TTM) P/B ratio 2.30
Dividend yield 3.16%
Last dividend (FY25) $2.80
Revenue growth (TTM) Revenue growth 2.72%
Revenue (TTM) Revenue $33.20b
EBIT (operating result TTM) EBIT $6.19b
Free Cash Flow (TTM) Free Cash Flow $5.47b
Cash position $7.92b
EPS (TTM) EPS $3.29
P/E forward 21.72
P/S forward 3.39
EV/Sales forward 3.95
Short interest 1.00%
Show more

Is Medtronic a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,807 stocks worldwide.

Medtronic Stock Analysis

Unlock Scores for Free

Analyst Opinions

33 Analysts have issued a Medtronic forecast:

15x Buy
45%
15x Hold
45%
3x Sell
9%

Analyst Opinions

33 Analysts have issued a Medtronic forecast:

Buy
45%
Hold
45%
Sell
9%

Financial data from Medtronic

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jan '25
+/-
%
33,199 33,199
3% 3%
100%
- Direct Costs 13,172 13,172
3% 3%
40%
20,027 20,027
3% 3%
60%
- Selling and Administrative Expenses 8,438 8,438
4% 4%
25%
- Research and Development Expense 2,723 2,723
1% 1%
8%
8,866 8,866
2% 2%
27%
- Depreciation and Amortization 2,675 2,675
0% 0%
8%
EBIT (Operating Income) EBIT 6,191 6,191
4% 4%
19%
Net Profit 4,259 4,259
1% 1%
13%

In millions USD.

Don't miss a Thing! We will send you all news about Medtronic directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Medtronic Stock News

Neutral
The Motley Fool
one day ago
Investing in this market isn't fun. Geopolitical tensions are escalating to levels not seen in decades, global trade relationships face unprecedented strain, and persistent inflation continues eroding purchasing power.
Positive
The Motley Fool
2 days ago
Medtronic (MDT 2.62%) stock was a fairly hot item as the trading week kicked off, with investors pushing the shares up by almost 3% in value. They liked the medical device specialist's latest piece of news about one of its products, and reacted accordingly.
Positive
Seeking Alpha
2 days ago
Dividend Aristocrats are outperforming the S&P 500 in 2025, demonstrating resilience, with NOBL up 1.78% YTD versus SPY's 4.9% decline. Top performers include Consolidated Edison (+22.98%), Brown & Brown (+20.65%), and AbbVie (+16.61%), showcasing strong double-digit gains. 29 out of 69 Dividend Aristocrats have announced dividend increases in 2025, with an average growth rate of 4.15%.
More Medtronic News

Company Profile

Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiac and Vascular Group; Minimally Invasive Technologies Group; Restorative Therapies Group; and Diabetes Group. The Cardiac and Vascular Group segment consist Cardiac Rhythm and Heart Failure, Coronary and Structural Heart, and Aortic and Peripheral Vascular divisions. The Minimally Invasive Technologies Group segment comprises Surgical Innovations and Respiratory, Gastrointestinal, and Renal divisions. The Restorative Therapies Group contains Spine, Brain, Specialty Therapies, and Pain Therapies divisions. The Diabetes Group segment focuses in the development, manufacturing, and marketing of products and services for the management of Type I and Type II diabetes. The company was founded in 1949 and is headquartered in Dublin, Ireland.

Head office United States
CEO Geoffrey Martha
Employees 95,000
Founded 2014
Website www.medtronic.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today